Protein in blood may predict how seniors react to sedation
NCT ID NCT07280663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed early-phase study looked at 128 older adults (60+) having knee replacement surgery. Researchers measured a protein called neurofilament light chain in the blood and checked how sensitive patients were to the sedative remazolam. The goal was to see if higher protein levels—which can indicate nerve damage—relate to needing less sedation or having more side effects. The findings could help doctors personalize anesthesia for elderly patients, but the study is small and only explores a possible link, not a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remazolam
What this could lead to
If successful, this could help anesthesiologists tailor sedation doses for older patients, potentially reducing risks like confusion or falls after surgery.
What could go wrong
This is a very early, small study (128 people) that only looks for a link between a protein and drug sensitivity. It does not test a new treatment, so direct benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLD AGE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China